BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Kannan Sridharan, Gowri Sivaramakrishnan, Reginald Paul Sequeira, Abdelaziz Elamin. Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysisPostgraduate Medical Journal 2018; 94(1116): 556 doi: 10.1136/postgradmedj-2018-135967
2
Arya M. Sharma. Differential indications for weight lossCurrent Opinion in Endocrine and Metabolic Research 2019; 4: 58 doi: 10.1016/j.coemr.2018.09.001
3
Mariane Róvero Costa, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Fabiane Valentini Francisqueti-Ferron, Fabiana Kurokawa Hasimoto, Cristina Schmitt Gregolin, Dijon Henrique Salomé de Campos, Cleverton Roberto de Andrade, Ana Lúcia dos Anjos Ferreira, Camila Renata Corrêa, Fernando Moreto. Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese RatsAntioxidants 2019; 8(8): 276 doi: 10.3390/antiox8080276
4
Yala K. Reddy, Hemnishil K. Marella, Yu Jiang, Surosree Ganguli, Peter Snell, Pradeep S.B. Podila, Benedict Maliakkal, Sanjaya K. Satapathy. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver BiopsiesJournal of Clinical and Experimental Hepatology 2019;  doi: 10.1016/j.jceh.2019.07.002
5
Bokyeong Ryu, Kyung-Yeon Eo, Ja-Jun Jang, C-Yoon Kim, Ji Min Lee, Hanseul Oh, Ukjin Kim, Jin Kim, Hyun-Ho Lee, Young-Mok Jung, Jae-Hak Park. A case of active incomplete biliary cirrhosis in an aged female Japanese macaque (Macaca fuscata )Journal of Medical Primatology 2018; 47(4): 270 doi: 10.1111/jmp.12347
6
Mohammad Hosein Farzaei, Amit Kumar Singh, Ramesh Kumar, Courtney R. Croley, Abhay K. Pandey, Ericsson Coy-Barrera, Jayanta Kumar Patra, Gitishree Das, Rout George Kerry, Giuseppe Annunziata, Gian Carlo Tenore, Haroon Khan, Matteo Micucci, Roberta Budriesi, Saeideh Momtaz, Seyed Mohammad Nabavi, Anupam Bishayee. Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic DisordersInternational Journal of Molecular Sciences 2019; 20(19): 4957 doi: 10.3390/ijms20194957
7
Manuel Suárez, Noemí Boqué, Josep del Bas, Jordi Mayneris-Perxachs, Lluís Arola, Antoni Caimari. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver DiseaseNutrients 2017; 9(10): 1052 doi: 10.3390/nu9101052
8
Stefan Drinda, Franziska Grundler, Thomas Neumann, Thomas Lehmann, Nico Steckhan, Andreas Michalsen, Francoise Wilhelmi de Toledo. Effects of Periodic Fasting on Fatty Liver Index—A Prospective Observational StudyNutrients 2019; 11(11): 2601 doi: 10.3390/nu11112601
9
Alessia Di Costanzo, Lucia Pacifico, Claudio Chiesa, Francesco Massimo Perla, Fabrizio Ceci, Antonio Angeloni, Laura D’Erasmo, Michele Di Martino, Marcello Arca. Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesityPediatric Research 2019; 85(5): 671 doi: 10.1038/s41390-019-0303-1
10
Luis Cano, Juan Pablo Cerapio, Eloy Ruiz, Agnès Marchio, Bruno Turlin, Sandro Casavilca, Luis Taxa, Guillaume Marti, Eric Deharo, Pascal Pineau, Stéphane Bertani. Liver clear cell foci and viral infection are associated with non-cirrhotic, non-fibrolamellar hepatocellular carcinoma in young patients from South AmericaScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-28286-0
11
Matteo Tardelli, Francesca V. Bruschi, Thierry Claudel, Claudia D. Fuchs, Nicole Auer, Victoria Kunczer, Tatjana Stojakovic, Hubert Scharnagl, Aida Habib, Gernot F. Grabner, Robert Zimmermann, Sophie Lotersztajn, Michael Trauner. Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorptionJournal of Lipid Research 2019; 60(7): 1284 doi: 10.1194/jlr.M093369
12
Laura Draijer, Marc Benninga, Bart Koot. Pediatric NAFLD: an overview and recent developments in diagnostics and treatmentExpert Review of Gastroenterology & Hepatology 2019; 13(5): 447 doi: 10.1080/17474124.2019.1595589
13
Cene Skubic, Živa Drakulić, Damjana Rozman. Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugsExpert Opinion on Drug Metabolism & Toxicology 2018; 14(8): 831 doi: 10.1080/17425255.2018.1492552
14
Guy Rostoker, Christelle Loridon, Mireille Griuncelli, Clémentine Rabaté, Fanny Lepeytre, Pablo Ureña-Torres, Belkacem Issad, Nasredine Ghali, Yves Cohen. Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept StudyEBioMedicine 2019; 39: 461 doi: 10.1016/j.ebiom.2018.11.020
15
Lipika Salaye, Ielizaveta Bychkova, Sandy Sink, Alexander J. Kovalic, Manish S. Bharadwaj, Felipe Lorenzo, Shalini Jain, Alexandria V. Harrison, Ashley T. Davis, Katherine Turnbull, Nuwan T. Meegalla, Soh-hyun Lee, Robert Cooksey, George L. Donati, Kylie Kavanagh, Herbert L. Bonkovsky, Donald A. McClain. A Low Iron Diet Protects from Steatohepatitis in a Mouse ModelNutrients 2019; 11(9): 2172 doi: 10.3390/nu11092172
16
Reggiani V. Gonçalves, Jamili D.B. Santos, Natanny S. Silva, Etienne Guillocheau, Robson E. Silva, Thaiany G. Souza-Silva, Rafael F. Oliveira, Eliziária C. Santos, Romulo D. Novaes. Trans-fatty acids aggravate anabolic steroid-induced metabolic disturbances and differential gene expression in muscle, pancreas and adipose tissueLife Sciences 2019; 232: 116603 doi: 10.1016/j.lfs.2019.116603
17
Eline H. van den Berg, Eke G. Gruppen, Richard W. James, Stephan J. L. Bakker, Robin P. F. Dullaart. Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterolJournal of Lipid Research 2019; 60(1): 168 doi: 10.1194/jlr.P088997
18
Harshul Pandit, Joseph P. Tinney, Yan Li, Guozhen Cui, Suping Li, Bradley B. Keller, Robert C.G. Martin. Utilizing Contrast-Enhanced Ultrasound Imaging for Evaluating Fatty Liver Disease Progression in Pre-clinical Mouse ModelsUltrasound in Medicine & Biology 2019; 45(2): 549 doi: 10.1016/j.ultrasmedbio.2018.10.011
19
Siavash Mehdizadeh Seraj, Abdullah Al-Zaghal, Mahdi Z. Zadeh, Pegah Jahangiri, Kamyar Pournazari, William Y. Raynor, Thomas J. Werner, Poul F. Høilund-Carlsen, Abass Alavi, Stephen J. Hunt. Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMINuclear Medicine Communications 2019; 40(5): 545 doi: 10.1097/MNM.0000000000001000
20
Justin D. Schumacher, Grace L. Guo. Bile Acids and Their ReceptorsHandbook of Experimental Pharmacology 2019; 256: 325 doi: 10.1007/164_2019_228
21
Zeynab Yousefi, Mitra Nourbakhsh, Zohreh Abdolvahabi, Seyedeh‐Sara Ghorbanhosseini, Zahra Hesari, Sahar Yarahmadi, Samira Ezzati‐Mobasser, Parvane Seiri, Mohammad Borji, Reza Meshkani, Mojtaba Malek. microRNA‐141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP‐activated protein kinase pathway in hepatocytesJournal of Cellular Physiology 2019;  doi: 10.1002/jcp.29002
22
Julie Rask Larsen, Lorena Dima, Christoph U. Correll, Peter Manu. The pharmacological management of metabolic syndromeExpert Review of Clinical Pharmacology 2018; 11(4): 397 doi: 10.1080/17512433.2018.1429910
23
Salwa Seddik Hosny, Hanan Mahmoud Ali, Wesam Ahmed Mohammed, Mohamed Hesham El Ghannam. Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DMDiabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(3): 1769 doi: 10.1016/j.dsx.2019.04.002
24
Esther van Eekelen, Anouk Geelen, Marjan Alssema, Hildo J Lamb, Albert de Roos, Frits R Rosendaal, Renée de Mutsert. Sweet Snacks Are Positively and Fruits and Vegetables Are Negatively Associated with Visceral or Liver Fat Content in Middle-Aged Men and WomenThe Journal of Nutrition 2019; 149(2): 304 doi: 10.1093/jn/nxy260
25
Maria Rubio-Ruiz, Verónica Guarner-Lans, Agustina Cano-Martínez, Eulises Díaz-Díaz, Linaloe Manzano-Pech, Anel Gamas-Magaña, Vicente Castrejón-Tellez, Concepción Tapia-Cortina, Israel Pérez-Torres. Resveratrol and Quercetin Administration Improves Antioxidant DEFENSES and reduces Fatty Liver in Metabolic Syndrome RatsMolecules 2019; 24(7): 1297 doi: 10.3390/molecules24071297
26
Aleksandra Klisic, Ludovico Abenavoli, Sharmila Fagoonee, Nebojsa Kavaric, Gordana Kocic, Ana Ninić. Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD scoreMinerva Medica 2019; 110(3) doi: 10.23736/S0026-4806.19.05978-0
27
René R. Balandrán-Quintana, Ana María Mendoza-Wilson. Bioactive Molecules in FoodReference Series in Phytochemistry 2019; : 295 doi: 10.1007/978-3-319-78030-6_57
28
Katharina L. Hupa, Elmar Jaeckel, Michael P. Manns. Silymarin for Treatment of Nonalcoholic Steatohepatitis–A New Kid on the Block?Clinical Gastroenterology and Hepatology 2017; 15(12): 1863 doi: 10.1016/j.cgh.2017.08.005
29
Ivan M. Petyaev, Pavel Y. Dovgalevsky, Natalia E. Chalyk, Victor A. Klochkov, Nigel H. Kyle, Yuriy K. Bashmakov. Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary ReportInternational Journal of Chronic Diseases 2018; 2018: 1 doi: 10.1155/2018/4549614
30
Ping Ye, Jijun Liu, Wuping Xu, Denghai Liu, Xiangchao Ding, Sheng Le, Hao Zhang, Shanshan Chen, Manhua Chen, Jiahong Xia. Dual‐Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta–Activated Kinase 1 SuppressionHepatology 2019; 69(5): 1946 doi: 10.1002/hep.30485
31
Hye In Kim, Jeon-Kyung Kim, Jae-Young Kim, Se-Eun Jang, Myung Joo Han, Dong-Hyun Kim. Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 simultaneously alleviate high-fat diet-induced colitis, endotoxemia, liver steatosis, and obesity in miceNutrition Research 2019; 67: 78 doi: 10.1016/j.nutres.2019.03.008
32
Cíntia Castro-Correia, Rita Santos-Silva, Marta Pinheiro, Carla Costa, Manuel Fontoura. Metabolic risk factors in adolescent girls with type 1 diabetesJournal of Pediatric Endocrinology and Metabolism 2018; 31(6): 631 doi: 10.1515/jpem-2018-0053
33
P. Melendez, M. Whitney, F. Williams, P. Pinedo, D. Manriquez, S.G. Moore, M.C. Lucy, P. Pithua, S.E. Poock. Technical note: Evaluation of fine needle aspiration cytology for the diagnosis of fatty liver in dairy cattleJournal of Dairy Science 2018; 101(5): 4483 doi: 10.3168/jds.2017-13346
34
David E. Stec, Darren M. Gordon, Jennifer A. Hipp, Stephen Hong, Zachary L. Mitchell, Natalia R. Franco, J. Walker Robison, Christopher D. Anderson, Donald F. Stec, Terry D. Hinds. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesityAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2019; 317(5): R733 doi: 10.1152/ajpregu.00153.2019
35
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang. Global Epidemiology, Prevention, and Management of Hepatocellular CarcinomaAmerican Society of Clinical Oncology Educational Book 2018; (38): 262 doi: 10.1200/EDBK_200939
36
Magdy M. Youssef, Amal Elshaer, Rizk Elbaz, Yehia A. Ellazek, Ahmad El-Waseef, Ahmad Settin. ApolipoproteinC3 Gene Variants in Nonalcoholic Fatty Liver Disease in EgyptAmerican Journal of Biochemistry and Molecular Biology 2018; 8(1): 16 doi: 10.3923/ajbmb.2018.16.22
37
Bo Wang, Yanghua Qu, Yiping Wang, Yong Ma, Chenchen Xu, Fadi Li, Ce Liu, Xiaonan Lu, Bo Wang, Peng Xiu, Yuefeng Gao, Zhicheng Diao, Yuxia Li, Hailing Luo. Triplet Male Lambs Are More Susceptible than Twins to Dietary Soybean Oil–Induced Fatty LiverThe Journal of Nutrition 2019; 149(6): 989 doi: 10.1093/jn/nxz039
38
E. Cipponeri, N. Vitturi, V. Mariano, F. Boscari, S. Galasso, C. Crepaldi, G. P. Fadini, S. Vigili de Kreutzenberg, M. C. Marescotti, E. Iori, F. Cavallin, L. Sartori, A. Baritussio, A. Avogaro, D. Bruttomesso. Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetesJournal of Endocrinological Investigation 2019; 42(9): 1099 doi: 10.1007/s40618-019-01031-8
39
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of DiabetesClinical Gastroenterology 2018; : 275 doi: 10.1007/978-3-319-75856-5_21
40
Eline H. van den Berg, James P. Corsetti, Stephan J. L. Bakker, Robin P. F. Dullaart, Petter Bjornstad. Plasma ApoE elevations are associated with NAFLD: The PREVEND StudyPLOS ONE 2019; 14(8): e0220659 doi: 10.1371/journal.pone.0220659
41
Ashley Cast, Meenasri Kumbaji, Amber D'Souza, Katherine Rodriguez, Anita Gupta, Rebekah Karns, Lubov Timchenko, Nikolai Timchenko. Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver DiseaseHepatology Communications 2019; 3(8): 1036 doi: 10.1002/hep4.1381
42
Resham Ramkissoon, Timothy B. Gardner. Pancreatic SteatosisThe American Journal of Gastroenterology 2019; 114(11): 1726 doi: 10.14309/ajg.0000000000000262
43
Alessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, Marialuisa Sponziello, Laura D’Erasmo, Licia Polimeni, Francesco Baratta, Daniele Pastori, Fabrizio Ceci, Anna Montali, Gabriella Girelli, Bruna De Masi, Antonio Angeloni, Giuseppe Giannini, Maria Del Ben, Francesco Angelico, Marcello Arca. Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing StrategyScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-21939-0
44
Christopher J. Schmoyer, Mohammad S. Siddiqui. Non-alcoholic Fatty Liver Disease in Non-obese PatientsCurrent Hepatology Reports 2017; 16(4): 382 doi: 10.1007/s11901-017-0377-3
45
Feng-Juan Yan, Yong-Jian Wang, Shi-Ran Yan, Jun Lu, Yuan-Lin Zheng. ZNF300 stimulates fatty acid oxidation and alleviates hepatosteatosis through regulating PPARαBiochemical Journal 2019; 476(2): 385 doi: 10.1042/BCJ20180517
46
Maria Kalogirou, Emmanouil Sinakos. Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?World Journal of Hepatology 2018; 10(11): 790-794 doi: 10.4254/wjh.v10.i11.790
47
Beyza Bulutoglu, Camilo Rey-Bedón, Young Bok (Abraham) Kang, Safak Mert, Martin L. Yarmush, O. Berk Usta. A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonationLab on a Chip 2019; 19(18): 3022 doi: 10.1039/C9LC00354A
48
Yu Seol Lee, Jeong Su Park, Da Hyun Lee, Dong-Kyu Lee, Sung Won Kwon, Byung-Wan Lee, Soo Han Bae. The Antidiabetic Drug Lobeglitazone Protects Mice From Lipogenesis-Induced Liver Injury via Mechanistic Target of Rapamycin Complex 1 InhibitionFrontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00539
49
Soufian Lasli, Han‐Jun Kim, KangJu Lee, Ceri‐Anne E. Suurmond, Marcus Goudie, Praveen Bandaru, Wujin Sun, Shiming Zhang, Niyuan Zhang, Samad Ahadian, Mehmet R. Dokmeci, Junmin Lee, Ali Khademhosseini. A Human Liver‐on‐a‐Chip Platform for Modeling Nonalcoholic Fatty Liver DiseaseAdvanced Biosystems 2019; 3(8): 1900104 doi: 10.1002/adbi.201900104
50
Zahra Maleki, Shima Jazayeri, Omid Eslami, Farzad Shidfar, Agha Fatemeh Hosseini, Shahram Agah, Hamed Norouzi. Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trialComplementary Therapies in Medicine 2019; 44: 44 doi: 10.1016/j.ctim.2019.02.020
51
Nicolás Salva-Pastor, Norberto C. Chávez-Tapia, Misael Uribe, Natalia Nuño-Lámbarri. Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver diseaseThe Journal of Steroid Biochemistry and Molecular Biology 2019; 194: 105445 doi: 10.1016/j.jsbmb.2019.105445
52
Nahum Mendez-Sanchez, Vania Cruz-Ramon, Oscar Ramirez-Perez, Jessica Hwang, Beatriz Barranco-Fragoso, Jaqueline Cordova-Gallardo. New Aspects of Lipotoxicity in Nonalcoholic SteatohepatitisInternational Journal of Molecular Sciences 2018; 19(7): 2034 doi: 10.3390/ijms19072034
53
Juan-Fen Mo, Jia-Yuan Wu, Li Zheng, Ya-Wei Yu, Tian-Xin Zhang, Li Guo, Yi Bao. Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese miceRSC Advances 2018; 8(54): 31194 doi: 10.1039/C8RA05915B
54
Wen-Chung Huang, Ya-Ling Chen, Hui-Chia Liu, Shu-Ju Wu, Chian-Jiun Liou. Ginkgolide C reduced oleic acid-induced lipid accumulation in HepG2 cellsSaudi Pharmaceutical Journal 2018; 26(8): 1178 doi: 10.1016/j.jsps.2018.07.006
55
Mark G. Swain, David E. J. Jones. Fatigue in chronic liver disease: New insights and therapeutic approachesLiver International 2019; 39(1): 6 doi: 10.1111/liv.13919
56
Arunaksharan Narayanankutty. Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic DiseasesCurrent Drug Targets 2019; 20(10): 1068 doi: 10.2174/1389450120666190222181506
57
Chris Boesch. Quantitative MR Imaging Is Increasingly Important in Liver DiseaseRadiology 2018; 286(2): 557 doi: 10.1148/radiol.2017172312
58
René R. Balandrán-Quintana, Ana María Mendoza-Wilson. SweetenersReference Series in Phytochemistry 2018; : 1 doi: 10.1007/978-3-319-54528-8_57-1
59
Pierangelo Torquato, Desirée Bartolini, Danilo Giusepponi, Marta Piroddi, Bartolomeo Sebastiani, Giorgio Saluti, Roberta Galarini, Francesco Galli. Increased plasma levels of the lipoperoxyl radical-derived vitamin E metabolite α-tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjectsFree Radical Biology and Medicine 2019; 131: 115 doi: 10.1016/j.freeradbiomed.2018.11.036
60
Hany A. Abdel Samie, Mohd Saeed, Syed Mohd Faisal, Mohd Adnan Kausar, Mohammad A. Kamal. Recent Findings on Nanotechnology-based Therapeutic Strategies Against Hepatocellular CarcinomaCurrent Drug Metabolism 2019; 20(4): 283 doi: 10.2174/1389200220666190308134351
61
Lucas Zangerolamo, Gabriela Moreira Soares, Jean Franciesco Vettorazzi, Maria Esméria do Amaral, Everardo Magalhães Carneiro, Sara Teresinha Olalla-Saad, Antonio Carlos Boschero, Helena Cristina Barbosa-Sampaio. ARHGAP21 deficiency impairs hepatic lipid metabolism and improves insulin signaling in lean and obese miceCanadian Journal of Physiology and Pharmacology 2019; 97(11): 1018 doi: 10.1139/cjpp-2018-0691
62
Maja Ðanić, Bojan Stanimirov, Nebojša Pavlović, Svetlana Goločorbin-Kon, Hani Al-Salami, Karmen Stankov, Momir Mikov. Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic SyndromeFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01382
63
Paul F. Lebeau, Jae Hyun Byun, Khrystyna Platko, Melissa E. MacDonald, Samantha V. Poon, Mahi Faiyaz, Nabil G. Seidah, Richard C. Austin. Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing de novo PCSK9 expression in miceJournal of Biological Chemistry 2019; 294(23): 9037 doi: 10.1074/jbc.RA119.008094
64
Berangere Gapp, Marie Jourdain, Pauline Bringer, Benjamin Kueng, Delphine Weber, Arnaud Osmont, Stefan Zurbruegg, Judith Knehr, Rocco Falchetto, Guglielmo Roma, William Dietrich, Reginald Valdez, Nicolau Beckmann, Florian Nigsch, Arun J. Sanyal, Iwona Ksiazek. Farnesoid X Receptor Agonism, Acetyl‐Coenzyme A Carboxylase Inhibition, and Back Translation of Clinically Observed Endpoints of De Novo Lipogenesis in a Murine NASH Model Hepatology Communications 2019;  doi: 10.1002/hep4.1443
65
Esther van Eekelen, Anouk Geelen, Marjan Alssema, Hildo J. Lamb, Albert de Roos, Frits R. Rosendaal, Renée de Mutsert. Adherence to dietary guidelines in relation to visceral fat and liver fat in middle-aged men and women: the NEO studyInternational Journal of Obesity 2019;  doi: 10.1038/s41366-019-0441-x
66
Amir Mohammad Kazemifar, Ali Akbar Shafikhani, Elaheh HajiNoormohammadi, Zahra Azarion, Aliakbar Hajiaghamohammadi. Investigating effect of Helicobacter pylori treatment on improvement of non-alcoholic fatty liver parameters: a randomized trialEgyptian Liver Journal 2019; 9(1) doi: 10.1186/s43066-019-0001-z
67
Yuhei Mizunoe, Masaki Kobayashi, Ryoma Tagawa, Yoshimi Nakagawa, Hitoshi Shimano, Yoshikazu Higami. Association between Lysosomal Dysfunction and Obesity-Related Pathology: A Key Knowledge to Prevent Metabolic SyndromeInternational Journal of Molecular Sciences 2019; 20(15): 3688 doi: 10.3390/ijms20153688
68
Shenzong Rao, Jingsong Huang, Zhijun Shen, Changgang Xiang, Min Zhang, Xueliang Lu. Inhibition of TREM‐1 attenuates inflammation and lipid accumulation in diet‐induced nonalcoholic fatty liver diseaseJournal of Cellular Biochemistry 2019; 120(7): 11867 doi: 10.1002/jcb.28468
69
Golnaz Ranjbar, Dimitri P. Mikhailidis, Amirhossein Sahebkar. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!Metabolism 2019; 101: 154001 doi: 10.1016/j.metabol.2019.154001
70
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. The Mexican consensus on nonalcoholic fatty liver diseaseRevista de Gastroenterología de México (English Edition) 2019; 84(1): 69 doi: 10.1016/j.rgmxen.2019.02.003
71
M. Bellan, M. Menegatti, C. Ferrari, G.P. Carnevale Schianca, M. Pirisi. Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practiceNutrition, Metabolism and Cardiovascular Diseases 2018; 28(6): 610 doi: 10.1016/j.numecd.2018.01.006
72
Kelsey Retting, Dwayne Carter, Candace Crogan-Grundy, Chirag Khatiwala, Leah Norona, Elizabeth Paffenroth, Umesh Hanumegowda, Alice Chen, Lisa Hazelwood, Lois Lehman-McKeeman, Sharon Presnell. Modeling Liver Biology and the Tissue Response to Injury in Bioprinted Human Liver TissuesApplied In Vitro Toxicology 2018; 4(3): 288 doi: 10.1089/aivt.2018.0015
73
Qian Chen, Mengyang Liu, Haiyang Yu, Jian Li, Sijian Wang, Yi Zhang, Feng Qiu, Tao Wang. Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathwayJournal of Natural Medicines 2018; 72(3): 655 doi: 10.1007/s11418-018-1199-5
74
Cátia Arieira, Sara Monteiro, Sofia Xavier, Francisca Dias de Castro, Joana Magalhães, Maria J. Moreira, Carla Marinho, José Cotter. Hepatic steatosis and patients with inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology 2019; 31(8): 998 doi: 10.1097/MEG.0000000000001319
75
Chang Li, Jing Ye, Yun Peng, Weiqiang Dou, Songan Shang, Jingtao Wu, Ramin Jafari, Kelly McCabe Gillen, Yi Wang, Martin Prince, Xianfu Luo. Evaluation of diffusion kurtosis imaging in stratification of nonalcoholic fatty liver disease and early diagnosis of nonalcoholic steatohepatitis in a rabbit modelMagnetic Resonance Imaging 2019; 63: 267 doi: 10.1016/j.mri.2019.08.032
76
Daniel R. Ludwig, Tyler J. Fraum, Roberto Cannella, Richard Tsai, Muhammad Naeem, Maverick LeBlanc, Amber Salter, Allan Tsung, Jaquelyn Fleckenstein, Anup S. Shetty, Amir A. Borhani, Alessandro Furlan, Kathryn J. Fowler. Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteriaHPB 2019;  doi: 10.1016/j.hpb.2019.04.007
77
Michelle Saoi, Kazunori Sasaki, Hitoshi Sagawa, Kaori Abe, Tomomi Kogiso, Katsutoshi Tokushige, Etsuko Hashimoto, Yoshiaki Ohashi, Philip Britz-McKibbin. High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage PathwayJournal of Proteome Research 2019;  doi: 10.1021/acs.jproteome.9b00405
78
Yi-Hsien Chang, Ya-Ling Chen, Wen-Chung Huang, Chian-Jiun Liou. Fucoxanthin attenuates fatty acid-induced lipid accumulation in FL83B hepatocytes through regulated Sirt1/AMPK signaling pathwayBiochemical and Biophysical Research Communications 2018; 495(1): 197 doi: 10.1016/j.bbrc.2017.11.022
79
Jinchunzi Yang, Marta Fernández-Galilea, Leyre Martínez-Fernández, Pedro González-Muniesa, Adriana Pérez-Chávez, J. Alfredo Martínez, Maria J. Moreno-Aliaga. Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid SupplementationNutrients 2019; 11(4): 872 doi: 10.3390/nu11040872
80
Marco Raffaele, Lars Bellner, Shailendra P. Singh, Gaia Favero, Rita Rezzani, Luigi Fabrizio Rodella, John R. Falck, Nader G. Abraham, Luca Vanella. Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in HO-1-PGC1α mitochondrial signalingExperimental Cell Research 2019; 380(2): 180 doi: 10.1016/j.yexcr.2019.04.029
81
Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov. Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromesDiabetes mellitus 2018; 20(6): 449 doi: 10.14341/DM9374
82
Eréndira Villanueva-Ortega, María José Garcés-Hernández, Arturo Herrera-Rosas, Juan Carlos López-Alvarenga, Estibalitz Laresgoiti-Servitje, Galileo Escobedo, Gloria Queipo, Sergio Cuevas-Covarrubias, Guadalupe Nayely Garibay-Nieto. Gender-specific differences in clinical and metabolic variables associated with NAFLD in a Mexican pediatric populationAnnals of Hepatology 2019; 18(5): 693 doi: 10.1016/j.aohep.2019.04.012
83
Karlijn J. Nass, Eline H. van den Berg, Eke G. Gruppen, Robin P. F. Dullaart. Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver diseaseEuropean Journal of Clinical Investigation 2018; 48(9): e12988 doi: 10.1111/eci.12988
84
R. Bernal-Reyes, G. Castro-Narro, R. Malé-Velázquez, R. Carmona-Sánchez, M.S. González-Huezo, I. García-Juárez, N. Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia, F. Bosques-Padilla, M. Castillo-Barradas, J.A. Chávez-Barrera, L. Cisneros-Garza, J. Flores-Calderón, D. García-Compeán, Y. Gutiérrez-Grobe, M.F. Higuera de la Tijera, D. Kershenobich-Stalnikowitz, L. Ladrón de Guevara-Cetina, J. Lizardi-Cervera, J.A. López-Cossio, S. Martínez-Vázquez, E. Márquez-Guillén, N. Méndez-Sánchez, R. Moreno-Alcantar, J.L. Poo-Ramírez, P. Ramos-Martínez, H. Rodríguez-Hernández, J.F. Sánchez-Ávila, M. Stoopen-Rometti, A. Torre-Delgadillo, G. Torres-Villalobos, R. Trejo-Estrada, M. Uribe-Esquivel, J.A. Velarde-Ruiz Velasco. Consenso mexicano de la enfermedad por hígado graso no alcohólicoRevista de Gastroenterología de México 2019; 84(1): 69 doi: 10.1016/j.rgmx.2018.11.007
85
Elizabeth J. Millings, Maria Caterina De Rosa, Sarah Fleet, Kazuhisa Watanabe, Richard Rausch, Dieter Egli, Gen Li, Charles A. Leduc, Yiying Zhang, Stuart G. Fischer, Rudolph L. Leibel, Leonidas G. Koniaris. ILDR2 has a negligible role in hepatic steatosisPLOS ONE 2018; 13(5): e0197548 doi: 10.1371/journal.pone.0197548
86
Eline H. van den Berg, Eke G. Gruppen, Sanam Ebtehaj, Stephan J.L. Bakker, Uwe J.F. Tietge, Robin P.F. Dullaart. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver diseaseAtherosclerosis 2018; 277: 21 doi: 10.1016/j.atherosclerosis.2018.07.028
87
Helda Tutunchi, Alireza Ostadrahimi, Maryam Saghafi‐Asl, Vahid Maleki. The effects of oleoylethanolamide, an endogenous PPAR‐α agonist, on risk factors for NAFLD: A systematic reviewObesity Reviews 2019; 20(7): 1057 doi: 10.1111/obr.12853
88
Junli Zhang, Haiming Zhang, Xiaoling Deng, Ning Zhang, Beibei Liu, Shengliang Xin, Guixin Li, Keshu Xu. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in miceLife Sciences 2018; 192: 46 doi: 10.1016/j.lfs.2017.11.027
89
Shu Liang, Yupei Zhang, Yuanjun Deng, Yifang He, Yinji Liang, Zien Liang, Yanning Chen, Kairui Tang, Runsen Chen, Qinhe Yang. The Potential Effect of Chinese Herbal Formula Hongqijiangzhi Fang in Improving NAFLD: Focusing on NLRP3 Inflammasome and Gut MicrobiotaEvidence-Based Complementary and Alternative Medicine 2018; 2018: 1 doi: 10.1155/2018/5378961
90
Rose Ghemrawi, Shyue-Fang Battaglia-Hsu, Carole Arnold. Endoplasmic Reticulum Stress in Metabolic DisordersCells 2018; 7(6): 63 doi: 10.3390/cells7060063
91
Hwa-Young Lee, Geum-Hwa Lee, Young Yoon, Han-Jung Chae. Rhus verniciflua and Eucommia ulmoides Protects Against High-Fat Diet-Induced Hepatic Steatosis by Enhancing Anti-Oxidation and AMPK ActivationThe American Journal of Chinese Medicine 2019; 47(06): 1253 doi: 10.1142/S0192415X19500642
92
Ernesto Cortes, Dariusz Lachowski, Alistair Rice, Antonios Chronopoulos, Benjamin Robinson, Stephen Thorpe, David A Lee, Lucia A Possamai, Haiyun Wang, David J Pinato, Armando E. del Río Hernández. Retinoic Acid Receptor-β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin-Driven Activation and Durotaxis in Hepatic Stellate CellsHepatology 2019; 69(2): 785 doi: 10.1002/hep.30193
93
Manca Povsic, Louisa Oliver, Neha Raju Jiandani, Richard Perry, Juliana Bottomley. A structured literature review of interventions used in the management of nonalcoholic steatohepatitis ( NASH ) Pharmacology Research & Perspectives 2019; 7(3): e00485 doi: 10.1002/prp2.485
94
Esteban Porrini, Maruja Navarro-Díaz, Rosa Rodríguez-Rodríguez, Eduardo Salido. Diabetic Nephropathy2019; : 65 doi: 10.1007/978-3-319-93521-8_5
95
Michelle L. Parker, Khosrow Adeli, Émile Lévy, Edgard Delvin. Are universal upper reference limits for alanine aminotransferase (ALT) appropriate for assessing pediatric liver injury?Clinical Biochemistry 2018; 53: 55 doi: 10.1016/j.clinbiochem.2018.01.010
96
Avner Ehrlich, Sabina Tsytkin-Kirschenzweig, Konstantinos Ioannidis, Muneef Ayyash, Anne Riu, Reine Note, Gladys Ouedraogo, Jan Vanfleteren, Merav Cohen, Yaakov Nahmias. Microphysiological flux balance platform unravels the dynamics of drug induced steatosisLab on a Chip 2018; 18(17): 2510 doi: 10.1039/C8LC00357B
97
Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese ChildrenInternational Journal of Molecular Sciences 2019; 20(18): 4444 doi: 10.3390/ijms20184444
98
Yuan Li, Shousheng Liu, Yuqiang Gao, Huan Ma, Shuhui Zhan, Yan Yang, Yongning Xin, Shiying Xuan. Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han PopulationJournal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2019.00010
99
Damien Viglino, Anais Plazanet, Sebastien Bailly, Meriem Benmerad, Ingrid Jullian-Desayes, Renaud Tamisier, Vincent Leroy, Jean-Pierre Zarski, Maxime Maignan, Marie Joyeux-Faure, Jean-Louis Pépin. Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary DiseaseScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-34988-2
100
Zaki A. Sherif. Nonalcoholic Fatty Liver Disease - An Update [Working Title]2019;  doi: 10.5772/intechopen.85780
101
Seon-Heui Cha, Yongha Hwang, Soo-Jin Heo, Hee-Sook Jun. Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic InflammationMarine Drugs 2019; 17(9): 486 doi: 10.3390/md17090486
102
Ludivine Renaud, Willian A. da Silveira, E. Starr Hazard, Jonathan Simpson, Silvia Falcinelli, Dongjun Chung, Oliana Carnevali, Gary Hardiman. The Plasticizer Bisphenol A Perturbs the Hepatic Epigenome: A Systems Level Analysis of the miRNomeGenes 2017; 8(10): 269 doi: 10.3390/genes8100269
103
Cong Wang, Shousheng Liu, Linlin Lu, Songling Liao, Haiyan Yue, Quanjiang Dong, Yongning Xin, Shiying Xuan. Association Between Four ABCA1 gene Polymorphisms and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Han PopulationHepatitis Monthly 2018; 18(6) doi: 10.5812/hepatmon.66149